Deep Dive: Deep Dive Into Psoriatic Arthritis

Terence Rooney, MD, explains the innovative research methods that Janssen utilizes and the benefits of precision medicine in the treatment of psoriatic arthritis and discusses the recent findings indicating that guselkumab provided patients with psoriatic arthritis with sustained improvements in health-related quality of life through 2 years. Rooney is Vice President and Rheumatology and Maternal-Fetal Immunology Disease Area Stronghold Leader at Janssen.